ALPRE.PA · Predilife S.A
-
-
| Sector | Healthcare |
|---|---|
| Exchange | PA |
| CurrencyCode | EUR |
| ISIN | FR0010169920 |
| Industry | Diagnostics & Research |
| Beta | 0.38 |
|---|---|
| Market Cap | 14M |
| PE Ratio | None |
| Target Price | 20.92 |
| Dividend Yield | None |
ABOUT
Predilife S.A
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
Learn More